Etiology

  • Premature birth
  • Maternal diabetes mellitus: leads to ↑ fetal insulin, which inhibits surfactant synthesis
  • Hereditary
  • Cesarean delivery: results in lower levels of fetal glucocorticoids than vaginal delivery, in which higher levels are released as a response to stress from uterine contractions
  • Hydrops fetalis
  • Multifetal pregnancies
  • Male sex

Pathophysiology

Surfactant deficiency

  • Little or no reduction of alveolar surface tension → increased alveolar collapse → atelectasis → decreased lung compliance and functional residual capacity → hypoxemia and hypercapnia

Clinical features

  • Maternal history of premature birth
  • Onset of symptoms: usually immediately after birth but can occur up to 72 hours postpartum
  • Signs of increased respiratory effort
    • Tachypnea
    • Nasal flaring and moderate to severe subcostal/intercostal and jugular retractions
  • Characteristic expiratory grunting
  • Decreased breath sounds on auscultation
  • Cyanosis due to pulmonary hypoxic vasoconstriction

Diagnostics


  • X-ray chestL57477.png
    • Interstitial pulmonary edema with perihilar streaking
    • Diffuse, fine, reticulogranular (ground-glass) densities with low lung volumes and air bronchograms
    • Atelectasis

Complications


Bronchopulmonary dysplasia (BPD)

  • Definition: chronic lung condition secondary to prolonged mechanical ventilation and oxygen therapy for NRDS
  • Etiology: Pulmonary barotrauma and oxygen toxicity with subsequent inflammation of lung tissue due to ventilation of the immature lung (ventilation for more than 28 days)
  • Clinical features
    • Seen in infants < 32 weeks
    • Persistence of symptoms similar to NRDS (e.g., tachypnea, grunting, nasal flaring)
    • Episodes of desaturation
  • Diagnostics
    • X-ray chest: diffuse, fine, granular densities, areas of atelectasis interspersed with areas of hyperinflation
    • Blood gas analysis: respiratory and metabolic acidosis
    • Histology: atelectasis, fibrosis, emphysematous alveolar changes (decreased number and septation of alveoli)
  • Treatment: controlled oxygenation, diuretics, rarely glucocorticoids